Since 1928, the world’s thought leaders in eye care have gathered to present their latest study data at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO).
Cataract & Refractive Surgery
Each year, the sheer volume of poster, paper and presentation abstracts is nothing short of astounding––possibly even overwhelming.
That’s precisely why Review has, yet again, asked four distinguished authors to sift through all the abstracts and highlight the most interesting and clinically relevant material presented at ARVO. And although this year the annual meeting was not hosted in sunny Ft. Lauderdale for the first time since 1995, the tremendous depth and quality of research still shined brightly.
Here’s a brief overview of our authors’ top picks in Review’s 14th Annual Report from ARVO:
Associate Clinical Editor Joseph P. Shovlin, OD, who also edits Review’s “Cornea and Contact Lens Q+A,” places a priority on clinical study data that can be used to help maximize your patients’ corneal health.
He discusses how surgeons and optometrists can better ensure the long-term safety and efficacy of transplant procedures, simply by knowing which patients are at the highest risk for graft failure. Also, he looks at how contact lens wear may affect keratoconus patients who have undergone corneal collagen crosslinking.
Long-time ARVO Report contributor Robert Cole III, OD, Emeritus Clinical Editor, reviews the diagnostic capabilities of advanced visual field testing, including flicker-defined form and frequency doubling technology perimetry.
Also, he discusses whether the insertion of punctal plugs infused with travoprost could be used as a viable sustained-release drug delivery system.
Cataract and Refractive Surgery
ARVO Report newcomer and Contributing Editor Derek Cunningham, OD, centers upon how optometrists can help optimize refractive outcomes.
Aside from introducing a handful of novel surgical techniques, he primarily focuses upon the pre- and postoperative treatment of dry eye and inflammation with a host of new and emerging topical agents.
Steven Ferrucci, OD, Editorial Board Member and fellow ARVO Report rookie, provides the most up-to-date research regarding the treatment of diabetic retinopathy, macular edema and age-related macular degeneration––including early study results on a novel systemic agent for geographic atropy.
Further, he previews the long-awaited, and somewhat disappointing, results from AREDS2.
To view any of the abstracts cited in the ARVO report that follows, go to www.arvo.org.